|









|
|
|
    
The
potential use of biological or chemical agents in acts of terrorism is
one of the United States' primary security concerns and has been the
subject of many recent preparatory efforts. As demonstrated during the
anthrax mailings of 2001, public health entities and practitioners will
be called upon to provide scientific expertise to government leaders,
media, victims, and the population at large in an event involving the
intentional release of biological agents. The public health response to
bioterrorism must also consider complex issues such as
interjurisdictional cooperation, federal-state relations, emergency
surge capacity, and responder liability.
This
portion of the Clearinghouse contains information to assist public
health systems in preparing their responses to bioterrorism.
|